Wells Fargo has downgraded Molina Healthcare (MOH) from Overweight to Equal-Weight, significantly lowering its price target from $208.00 to $141.00, a 32.21% decrease. This downgrade aligns with a trend of cautious adjustments from other analysts, reflecting evolving market conditions and company performance. Despite these downgrades, the average target price from 16 analysts suggests a 6.44% upside, while GuruFocus estimates a significant upside of 200.89% based on its GF Value.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Molina Healthcare (MOH) Downgraded by Wells Fargo with Price Target Lowered
Wells Fargo has downgraded Molina Healthcare (MOH) from Overweight to Equal-Weight, significantly lowering its price target from $208.00 to $141.00, a 32.21% decrease. This downgrade aligns with a trend of cautious adjustments from other analysts, reflecting evolving market conditions and company performance. Despite these downgrades, the average target price from 16 analysts suggests a 6.44% upside, while GuruFocus estimates a significant upside of 200.89% based on its GF Value.